The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BHP GROUP LTD-SPON ADR | COM | 088606108 | 1,889 | 27,660 | SH | SOLE | 1 | 0 | 0 | |||
| EQT CORP | COM | 26884L109 | 5,847 | 151,259 | SH | SOLE | 1 | 0 | 0 | |||
| META PLATFORMS INC-CLASS A | COM | 30303M102 | 3,748 | 10,589 | SH | SOLE | 1 | 0 | 0 | |||
| HOVNANIAN ENTERPRISES-A | COM | 442487401 | 602 | 3,872 | SH | SOLE | 1 | 0 | 0 | |||
| ISHARES MSCI SINGAPORE ETF | COM | 46434G780 | 254 | 13,600 | SH | SOLE | 1 | 0 | 0 | |||
| OMNIAB INC | COM | 68218J103 | 1,544 | 250,185 | SH | SOLE | 1 | 0 | 0 | |||
| OVID THERAPEUTICS INC | COM | 690469101 | 4,249 | 1,319,679 | SH | SOLE | 1 | 0 | 0 | |||
| RANGE RESOURCES CORP | COM | 75281A109 | 1,459 | 47,923 | SH | SOLE | 1 | 0 | 0 | |||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 220 | 250 | SH | SOLE | 1 | 0 | 0 | |||
| RIO TINTO PLC-SPON ADR | COM | 767204100 | 1,809 | 24,300 | SH | SOLE | 1 | 0 | 0 | |||
| VALE SA-SP ADR | COM | 91912E105 | 4,568 | 28,800 | SH | SOLE | 1 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,518 | 32,956 | SH | SOLE | 1 | 0 | 0 | |||
| XOMA CORP | COM | 98419J206 | 2,229 | 120,465 | SH | SOLE | 1 | 0 | 0 | |||
| YANDEX NV-A | COM | N97284958 | 0 | 17,811 | SH | SOLE | 1 | 0 | 0 | |||
| SPDR S&P 500 ETF TR | COM | 78462F103 | 202 | 500 | SH | SOLE | 1 | 0 | 0 | |||